The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma.Vise andre og tillknytning
2005 (engelsk)Inngår i: Blood, ISSN 0006-4971, Vol. 105, nr 12, s. 4894-5; author reply 4895Artikkel i tidsskrift (Annet vitenskapelig) Published
sted, utgiver, år, opplag, sider
2005. Vol. 105, nr 12, s. 4894-5; author reply 4895
Emneord [en]
Alleles, Gene Frequency, Genotype, Humans, Interleukin-10/*genetics, Lymphoma; B-Cell/*genetics/therapy, Lymphoma; Large-Cell; Diffuse/*genetics/therapy, Polymorphism; Genetic, Prognosis, Promoter Regions (Genetics), Remission Induction, Time Factors, Treatment Outcome
Identifikatorer
URN: urn:nbn:se:uu:diva-80443PubMedID: 15933064OAI: oai:DiVA.org:uu-80443DiVA, id: diva2:108357
2006-05-102006-05-102011-01-11